Advertisement

Schaumzellanalyse

  • Biörn Ivemark

Zusammenfassung

Schaumzellen sind Makrophagen mit fremdem Inhalt. Sie kommen bei manchen Krankheiten vor und erscheinen im Paraffinschnitt als große Zellen mit hellem, körnigem oder „schaumigem“Zytoplasma und einem kleinen Kern. Im allgemeinen ist es nicht möglich, am Paraffinschnitt den Inhalt dieser Zellen und damit ihre Bedeutung abzuklären. Im folgenden wird eine Zusammenstellung generalisierter Prozesse, oft metabolischer Art, präsentiert. Damit sind alle lokalisierten Prozesse ausgeschlossen, wie z.B. echte Tumoren (Hypernephrom, alveoläres Weichteilsarkom, Myxom), Knochenveränderungen des Typs fibröse Dysplasie, nicht ossifizierende Fibrome sowie in den Nieren auftretende Schaumzellen lokalen Ursprungs, die bei vielen Krankheiten vorkommen können (Zollinger und Rohr, 1969).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Kamoshita, S., Landing, B. H.: Distribution of lesions in myenteric plexus and gastrointestinal mucosa in lipidoses and other neurological disorders in children. Amer. J. clin. Path. 49, 312 (1968).Google Scholar
  2. Wolman, M.: Histochemistry of lipids in pathology. In Handbuch der Histochemie (Hrsg. Graumann & Neumann), vol. V: 2. Stuttgart: Gustav Fischer 1964.Google Scholar
  3. Wolman, M.: Pigments in Pathology. New York: Academic Press 1969.Google Scholar
  4. Yunis, E., Sherman, F. E.: Macrophages of the rectal lamina propria in children. Amer. J. clin. Path. 53, 580 (1970).Google Scholar
  5. Zollinger, H. U., Rohr, H.-P.: Struktur und Bedeutung der renalen Schaumzellen. Vir-chows Arch. Abt. A 348, 205 (1969).CrossRefGoogle Scholar

Ceroid

  1. Fisher, E. R.: Pigmentation of intestinal tract. In Pigments in Pathology (Hrsg. Wolman, M.), S. 489. New York: Academic Press 1969.Google Scholar
  2. Fisher, E. R., Hellström, H. R.: Ceroid-like colonic histiocytosis. Amer. J. clin. Path. 42, 581 (1964).Google Scholar
  3. Oppenheimer, E., Andrews, Jr., E. A.: Ceroid storage disease in childhood, Pediatrics 23, 1091 (1959).PubMedGoogle Scholar

Chronische Granulomatose

  1. Barnes, R. D., Bishun, N. P., Holliday, J.: Impaired lymphocyte transformation and chromosomal abnormalities in fatal granulomatous disease of childhood. Acta paediat. scand. 59, 403 (1970).PubMedCrossRefGoogle Scholar
  2. Clawson, C. C., Rodey, G. E., Good, R. A.: Ultrastructure of familial lipochrome histiocytosis. Lab. Invest. 22, 294 (1970).PubMedGoogle Scholar
  3. Eschenbach, C.: Zur Aetiologie der progressiven septischen Granulomatose. Pediat. Res. 4, 493 (1970).PubMedCrossRefGoogle Scholar
  4. Eschenbach, C., Seebach, G.: Anomalie der Lysosomenmembran von neutrophilen Granu-locyten als Ursache der progressiven septischen Granulomatose. Virchows Arch. Abt. B 7, 16 (1971).Google Scholar
  5. Heyne, K.: Progressive septische Granulomatose (chronic granulomatous disease) im Säuglingsalter. Acta paediat. Acad. Sci. hung. 12, 137 (1971).PubMedGoogle Scholar
  6. Hitzig, W. H., Molz, G., Plüss, H. J., Renner, R.: Progressive septische Granulomatose. Helv. paediat. Acta 24, 246 (1969).Google Scholar
  7. Johnston, R. B., Baehner, R. L.: Chronic granulomatous disease: Correlation between pathogenesis and clinical findings. Pediatrics 48, 730 (1971).PubMedGoogle Scholar
  8. Krěpela, K., Zástava, V., Kučerová, M., Bukva, V., Hamanová, J.: Fatal familial granulomatosis in children. Helv. paediat. Acta 25, 428 (1970).PubMedGoogle Scholar
  9. Quie, P. G.: Chronic granulomatous disease of childhood. Advanc. Pediat. 16, 287 (1969).Google Scholar
  10. Symchych, P. S., Wanstrup, J., Andersen, V.: Chronic granulomatous disease of childhood. A morphologic study. Acta path. microbiol. scand. 74, 179 (1968).PubMedCrossRefGoogle Scholar
  11. Thompson, E. N., Soothill, J. F.: Chronic granulomatous disease: Quantitative clinicopa-thological relationships. Arch. Dis. Childh. 45, 24 (1970).PubMedCrossRefGoogle Scholar

Cortison-Lipidose

  1. Breckenridge, R. T., Moore, R. D., Ratnoff, O. D.: A study of thrombocytopenia. New histologic criteria of the differentiation of idiopathic thrombocytopenia and the thrombocytopenia associated with disseminated lupus erythematosus. Blood 30, 39 (1967).PubMedGoogle Scholar
  2. Dollberg, L., Casper, J., Djaldetti, M., Klibansky, Ch., De Vries, A.: Lipid-laden histiocytes in the spleen in thrombocytopenic purpura. Amer. J. clin. Path. 43, 16 (1965).Google Scholar
  3. Hill, J. M., Speer, R. J., Gedikoglu, H.: Secondary lipidosis of spleen associated with thrombocytopenia and other blood dyspasias treated with cortisone. Amer. J. clin. Path. 39, 607 (1963).Google Scholar
  4. Landing, B. H., Strauss, L., Crocker, A. C., Braunstein, H., Henley, W. L., Will, J. R., Sanders, M.: Thrombocytopenic purpura with histiocytosis of the spleen. New Engl. J. Med. 265, 572 (1961).PubMedCrossRefGoogle Scholar
  5. Speer, R. J., Ridgway, H., Hill, J. M.: Lipids of the human spleen. Amer. J. clin. Path. 38, 297 (1962).Google Scholar

Essentielle Hypercholesterinaemie und Lipaemie

  1. Borrie, P.: Essential hyperlipemia and idiopathic hypercholesterolaemic xanthomatosis. Brit. med. J. 11, 911 (1957).CrossRefGoogle Scholar
  2. Ferrans, V. J., Buja, L. M., Roberts, W. C., Fredrickson, D. S.: The spleen in type I hyperlipoproteinemia. Amer. J. Path. 64, 67 (1971).PubMedGoogle Scholar
  3. Goodman, M., Shuman, H., Goodman, S.: Idio-pathic lipemia with secondary xanthomatosis, hepatosplenomegaly, and lipemia retinate. J. Pediat. 16, 598 (1940).CrossRefGoogle Scholar
  4. Kinsell, L. W., Schlierf, G., Kahlke, W., Schettler, G.: Essential hyperlipemia. In Lipids and Lipidoses (Hrsg. G. Schettler), S. 446. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  5. Schettler, G., Kahlke, W., Schlierf, G.: Essential hypercholesterolemia. In Lipids and Lipidoses (Hrsg. G. Schettler), S. 412. Berlin-Heidelberg-New York: Springer 1967.Google Scholar

Fabry’sche Glykolipidose

  1. Brady, R. O., Gal, A. E., Bradley, R. M., Mårtensson, E.: The metabolism of ceramid trihexosides. J. biol. Chem. 242, 1021 (1967).PubMedGoogle Scholar
  2. Brady, R. O., Gal, A. E., Bradley, R. M., Mårtensson, E., Warshaw, A.L., Laster, L.: Enzymatic defect in Fabry’s disease. New Engl. J. Med. 276, 1163 (1967).PubMedCrossRefGoogle Scholar
  3. Desnick, R. J., Sweeley, C. C., Krivit, W.: A method for the quantitative determination of neutral glycosphingolipids in urine sediment. J. Lipid Res. 11, 31 (1970).PubMedGoogle Scholar
  4. Francois, J., Snacken, J., Stockmans, L.: Fabry’s disease (glycolipid lipidoses). Path. europ. 3, 347 (1968).Google Scholar
  5. Kint, J. A.: Fabry’s disease: Alpha-galactosidase deficiency. Science 167, 1268 (1970).PubMedCrossRefGoogle Scholar
  6. Malmqvist, E., Ivemark B. I., Lindsten, K. J., Maunsbach, A., Mårtensson, E.: Histochemical, electronmicroscopical and biochemical studies on Fabry’s disease in a family with evidence of linkage with the sex-linked blood group Xg. Lab. Invest. 25, 1 (1971).PubMedGoogle Scholar
  7. Philippart, M., Sarlieve, L., Mancorda, A.: Urinary glycolipids in Fabry’s disease. Their examination in the detection of atypical variants and the pre-symptomatic state. Pediatrics 43, 201 (1969).PubMedGoogle Scholar
  8. Sweeley, C. C., Klionsky, B., Desnick, R. J., Krivit, W.: Fabry’s disease: Glycosphingolipid lipidosis. In The Metabolic Basis of Inherited Disease (Hrsg. Stanbury et al.), 3. Aufl. New York: MacGraw-Hill 1972.Google Scholar

Farbersche Lipogranulomatose

  1. Crocker, A. C., Cohen, J., Farber, S.: The „lipogranulomatosis“syndrome; Review with report of patient showing milder involvement. In Inborn Disorders of Sphingolipid Metabolism (Hrsg. Aronson & Volk), S. 485. Oxford: Pergamon 1967.Google Scholar
  2. Eleftheriou, D., Vlachos, J., Billis, A.: Fatal li-pogranulomatosis with atrial pseudotumour, intrahepatic sclerosing cholangitis and lymphoreticular proliferation simulating malignant lymphoma. Path. europ. 5, 348 (1970).Google Scholar
  3. Molz, G.: Farbersche Krankheit. Pathologischanatomische Befunde. Virchows Arch. Abt. A 344, 86 (1968).CrossRefGoogle Scholar
  4. Moser, H. W., Prensky, A. L., Wolfe, H. J., Rosman, N. P.: Farber’s lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside. Amer. J. Med. 47, 869 (1969).PubMedCrossRefGoogle Scholar
  5. Samuelsson, K., Zetterström, R.: Ceramides in a patient with lipogranulomatosis (Farber’s disease) with chronic course. Scand. J. clin. Lab. Invest. 27, 393 (1971).PubMedCrossRefGoogle Scholar
  6. Samuelsson, K., Zetterström, R., Ivemark, B. I.: Studies on a case of lipogranulomatosis (Farber’s disease) with protracted course. 4th International Symposium on Sphingoli-pids, Sphingolipidoses and Allied Disorders. New York: Plenum Press 1972.Google Scholar

Gangliosidose

  1. O’Brien, J. S.: Generalized gangliosidoses. J. Pediat. 75, 167 (1969).PubMedCrossRefGoogle Scholar
  2. Schettler, G., Kahlke, W.: Neurovisceral gangliosidoses. In Lipids and Lipidoses (Hrsg. Schettler), S. 242. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  3. Scott, C. R., Lagunoff, D., Trump, B. F.: Familial neurovisceral lipidosis. J. Pediat. 71, 357 (1967).PubMedCrossRefGoogle Scholar
  4. Suzuki, K.: Cerebral GM-1 gangliosidosis: Chemical pathology of visceral organs. Science 159, 1471 (1968).PubMedCrossRefGoogle Scholar

Melanose und Mukoidophagen

  1. Azzopardi, J. G., Evans, D. J.: Mucoprotein-containing histiocytes (muciphages) in the rectum. J. clin. Path. 19, 368 (1966).PubMedCrossRefGoogle Scholar

Morbus Gaucher

  1. Fredrickson, D. S.: Cerebroside lipidosis: Gaucher’s Disease. In The Metabolic Basis of Inherited Disease (Hrsg. Stanbury et al.), S. 730. New York: McGraw-Hill 1972.Google Scholar

Niemann-Picksche Krankheit

  1. Fredrickson, D.: Sphingomyelin lipidosis: Niemann-Pick disease. In The Metabolic Basis of Inherited Disease (Hrsg. Stanbury et al.), S. 586. New York: McGraw-Hill 1966.Google Scholar
  2. Ivemark, B. I., Svennerholm, L., Thorén, C., Tunell, R.: Niemann-Pick disease in infancy. Report of two siblings with clinical, histologic and chemical studies. Acta paediat. 52, 391 (1963).CrossRefGoogle Scholar
  3. Schettler, G., Kahlke, W.: Niemann-Pick disease. In Lipids and Lipidoses (Hrsg. Schettler), S. 288, Berlin-Heidelberg-New York: Springer 1967.Google Scholar

Schaumzellen bei Thalassaemie

  1. Gordon, G. B., Hyun, B. H., Kuhn, M. L.: Pathogenesis of the foam cell in thalassemia. Lab. Med. Bull Path. 10, 398 (1969).Google Scholar

Schaumzellen in den Nieren

  1. Zollinger, H. U., Rohr, H.-P.: Struktur und Bedeutung der renalen Schaumzellen. Vir-chows Arch. Abt. A 348, 205 (1969).CrossRefGoogle Scholar

Sulfatidose

  1. Kohn, R.: Papillomatosis of the gallbladder in metachromatic leukodystrophy. Amer. J. clin. Path. 52, 737 (1969). (Siehe auch Kap. 5.)Google Scholar

Tangiersche Krankheit

  1. Bale, P. M., Clifton-Bligh, P., Benjamin, B. N. P., Whyte, H. M.: Pathology of Tangier disease. J. clin. Path. 24, 609 (1971).PubMedCrossRefGoogle Scholar
  2. Fredrickson, D.: Familial high-density lipoprotein deficiency: Tangier disease. In The Metabolic Basis of Inherited Disease (Hrsg. Stanbury, Wyngaarden & Fredrickson), S. 520, 3. Aufl. New York: McGraw-Hill 1972.Google Scholar
  3. Kahlke, W.: Tangier disease. In Lipids and Lipidoses (Hrsg. Schettler), S. 401. Berlin-Heidelberg-New York: Springer 1967.Google Scholar

Whipplesche Krankheit

  1. Aust, C. H., Smith, E. B.: Whipple’s disease in a 3-month-old infant with involvement of the bone marrow. Amer. J. clin. Path. 37, 66 (1962).Google Scholar
  2. Maizel, H., Ruffin, J. M., Dobbins, W. O.: Whipple’s disease. A review of 19 patients from one hospital and a review of the literature since 1950. Medicine (Baltimore) 49, 175 (1970).Google Scholar
  3. Phillips, M. J., Finlay, J. M.: Bacilli-lipid associations in Whipple’s disease. J. Path. Bact. 94, 131 (1967).PubMedCrossRefGoogle Scholar
  4. Roberts, D. M., Themann, H., Knust, F.-J., Preston, F. E., Donaldson, J. R.: An electron-microscope study of bacteria in two cases of Whipple’s disease. J. Path. 100, 249 (1970).PubMedCrossRefGoogle Scholar
  5. Rowlands, D. T., Landing, B. H.: Colonic histiocytosis in children. Report of a form resembling that seen in Whipple’s disease. Amer. J. Path. 36, 201 (1960).PubMedGoogle Scholar

Wolmansche Krankheit

  1. Kahana, D., Berant, M., Wolman, M.: Primary familial xanthomatosis with adrenal involvement (Wolman’s disease). Report of a further case with nervous system involvement and pathogenetic considerations. Pediatrics 42, 70 (1968).PubMedGoogle Scholar
  2. Lake, B. D., Patrick, A. S.: Wolman’s disease: Deficiency of E 600-resistant acid esterase activity with storage of lipids in lysosomes. J. Pediat. 76, 262 (1970).PubMedCrossRefGoogle Scholar
  3. Lough, J., Fawcett, J., Wiegensberg, B.: Wolman’s disease. An electron microscopic, histochemical, and biochemical study. Arch. Path. 89, 163 (1970).Google Scholar
  4. Marshall, W. C., Ockenden, B. G., Fosbrocke, A. S., Cumings, J. N.: Wolman’s disease. A rare lipidosis with adrenal calcification. Arch. Dis. Childh. 44, 331 (1969).PubMedCrossRefGoogle Scholar

Copyright information

© Biörn Ivemark und Almqvist & Wiksell Förlag AB, Stockholm 1974

Authors and Affiliations

  • Biörn Ivemark
    • 1
  1. 1.Institutet för pediatrisk patologiKarolinska sjukhusetStrockholm 60Schweden

Personalised recommendations